Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J K Sherwood

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Lancet (London, England)|November 24, 1984
Cimetidine and primary hyperparathyroidismJ K Sherwood, F W Ackroyd, M Garcia
Lancet (London, England)|March 22, 1980
Effect of cimetidine on circulating parathyroid hormone in primary hyperparathyroidismJ K Sherwood, F W Ackroyd, M Garcia
Lancet (London, England)|June 14, 1980
Cimetidine in hyperparathyroidismJ K Sherwood, F W Ackroyd, M Garcia
Bio/Technology (Nature Publishing Company)|November 1, 1992
Controlled antibody delivery systemsJ K Sherwood, R B Dause, W M Saltzman
Nature Biotechnology|March 6, 1998
Topical antibody delivery systems produce sustained levels in mucosal tissue and bloodP Y Kuo, J K Sherwood, W M Saltzman
Biotechnology and Bioengineering|January 5, 2000
Long-term vaginal antibody delivery: delivery systems and biodistributionW M Saltzman, J K Sherwood, D R Adams, et al.
Nature Biotechnology|April 1, 1996
Controlled release of antibodies for long-term topical passive immunoprotection of female mice against genital herpesJ K Sherwood, L Zeitlin, K J Whaley, et al.
Tissue Engineering|November 6, 2001
Effect of pore size and void fraction on cellular adhesion, proliferation, and matrix depositionJ Zeltinger, J K Sherwood, D A Graham, et al.
The American Surgeon|June 1, 1986
Hyperparathyroid crisis reviewed: a role for parenteral cimetidine?J K Sherwood, M Garcia, F W Ackroyd, et al.
Biology of Reproduction|January 1, 1996
Residence half-life of IgG administered topically to the mouse vaginaJ K Sherwood, L Zeitlin, X Chen, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Lancet (London, England)|November 24, 1984
Cimetidine and primary hyperparathyroidismJ K Sherwood, F W Ackroyd, M Garcia
Lancet (London, England)|March 22, 1980
Effect of cimetidine on circulating parathyroid hormone in primary hyperparathyroidismJ K Sherwood, F W Ackroyd, M Garcia
Lancet (London, England)|June 14, 1980
Cimetidine in hyperparathyroidismJ K Sherwood, F W Ackroyd, M Garcia
Bio/Technology (Nature Publishing Company)|November 1, 1992
Controlled antibody delivery systemsJ K Sherwood, R B Dause, W M Saltzman
Nature Biotechnology|March 6, 1998
Topical antibody delivery systems produce sustained levels in mucosal tissue and bloodP Y Kuo, J K Sherwood, W M Saltzman
Biotechnology and Bioengineering|January 5, 2000
Long-term vaginal antibody delivery: delivery systems and biodistributionW M Saltzman, J K Sherwood, D R Adams, et al.
Nature Biotechnology|April 1, 1996
Controlled release of antibodies for long-term topical passive immunoprotection of female mice against genital herpesJ K Sherwood, L Zeitlin, K J Whaley, et al.
Tissue Engineering|November 6, 2001
Effect of pore size and void fraction on cellular adhesion, proliferation, and matrix depositionJ Zeltinger, J K Sherwood, D A Graham, et al.
The American Surgeon|June 1, 1986
Hyperparathyroid crisis reviewed: a role for parenteral cimetidine?J K Sherwood, M Garcia, F W Ackroyd, et al.
Biology of Reproduction|January 1, 1996
Residence half-life of IgG administered topically to the mouse vaginaJ K Sherwood, L Zeitlin, X Chen, et al.
Pageof 2